NOVO-ETODOLAC 200 MG 200 MG
ETODOLAC : 200 MG · DIN 02242205 · NOVOPHARM LIMITED
Health Canada status: CANCELLED PRE MARKET
What is NOVO-ETODOLAC 200 MG?
NOVO-ETODOLAC 200 MG 200 MG contains ETODOLAC : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02242205, held by NOVOPHARM LIMITED, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 24-Jul-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242205 |
|---|---|
| Brand name | NOVO-ETODOLAC 200 MG |
| Generic / active ingredient | ETODOLAC : 200 MG |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 200 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AB08 ETODOLAC |
| AHFS class | 48:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 24-Jul-2018 |
| Original market date | 2001-03-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02242205 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2242205 |
| Brand name | NOVO-ETODOLAC 200 MG |
| Active ingredient / INN | ETODOLAC : 200 MG |
| ATC code | M01AB08 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M01 |
| AHFS class | 48:08.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | NOVOPHARM LIMITED |
Which pack is which?
| Strength on the label | 200 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code M01AB08 ETODOLAC. 0 of 12 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ETODOLAC | 200 MG | CAPSULE | APOTEX INC | APPROVED | DIN 02231965 |
| ETODOLAC | 200 MG | CAPSULE | AA PHARMA INC | DORMANT | DIN 02232317 |
| ETODOLAC | 300 MG | CAPSULE | APOTEX INC | APPROVED | DIN 02231967 |
| ETODOLAC | 300 MG | CAPSULE | AA PHARMA INC | DORMANT | DIN 02232318 |
| GEN-ETODOLAC 200MG | 200 MG | CAPSULE | GENPHARM ULC | CANCELLED POST MARKET | DIN 02239319 |
| GEN-ETODOLAC 300MG | 300 MG | CAPSULE | GENPHARM ULC | CANCELLED POST MARKET | DIN 02239320 |
| NOVO-ETODOLAC 300 MG | 300 MG | CAPSULE | NOVOPHARM LIMITED | CANCELLED PRE MARKET | DIN 02242206 |
| TARO-ETODOLAC | 300 MG | CAPSULE | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02242915 |
| TARO-ETODOLAC 200 MG | 200 MG | CAPSULE | TARO PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02242914 |
| ULTRADOL - CAP 200MG | 200 MG | CAPSULE | PROCTER & GAMBLE PHARMACEUTICALS CANADA INC | CANCELLED POST MARKET | DIN 02142023 |
How much does ETODOLAC cost around the world?
ETODOLAC is listed on 2 national price registers Nexara tracks, across 23 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 4 | 22 | 03 Sep 2026 |
| Saudi Arabia | public | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.